HEADER TRANSFERASE 08-NOV-07 2VG5 TITLE CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH TITLE 2 THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GAG-POL POLYPROTEIN P66 SUBUNIT, RESIDUES 600-1156; COMPND 5 SYNONYM: HIV-1 REVERSE TRANSCRIPTASE, P66 RT; COMPND 6 EC: 2.7.7.49, 2.7.7.7, 3.1.26.4; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: P51 RT; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: GAG-POL POLYPROTEIN P51 SUBUNIT, RESIDUES 600-1027; COMPND 12 SYNONYM: HIV-1 REVERSE TRANSCRIPTASE; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 9 ORGANISM_COMMON: HIV-1; SOURCE 10 ORGANISM_TAXID: 11676; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DNA-DIRECTED DNA POLYMERASE, THIOCARBAMATES, PHOSPHORYLATION, DNA KEYWDS 2 INTEGRATION, MAGNESIUM, ZINC-FINGER, RNA-BINDING, TRANSFERASE, KEYWDS 3 LIPOPROTEIN, CORE PROTEIN, ENDONUCLEASE, METAL-BINDING, ZINC, AIDS, KEYWDS 4 HIV-1, VIRION, NUCLEUS, MEMBRANE, ASPARTYL PROTEASE, CAPSID KEYWDS 5 MATURATION, MULTIFUNCTIONAL ENZYME, RNA-DIRECTED DNA POLYMERASE, KEYWDS 6 REVERSE TRANSCRIPTASE, NUCLEOTIDYLTRANSFERASE, DNA RECOMBINATION, KEYWDS 7 VIRAL NUCLEOPROTEIN, PROTEASE, NUCLEASE, MYRISTATE, HYDROLASE, KEYWDS 8 CYTOPLASM, NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS EXPDTA X-RAY DIFFRACTION AUTHOR A.SPALLAROSSA,S.CESARINI,A.RANISE,M.PONASSI,T.UNGE,M.BOLOGNESI REVDAT 5 08-MAY-24 2VG5 1 REMARK REVDAT 4 17-JAN-18 2VG5 1 REMARK REVDAT 3 24-FEB-09 2VG5 1 VERSN REVDAT 2 25-DEC-07 2VG5 1 JRNL REVDAT 1 11-DEC-07 2VG5 0 JRNL AUTH A.SPALLAROSSA,S.CESARINI,A.RANISE,M.PONASSI,T.UNGE, JRNL AUTH 2 M.BOLOGNESI JRNL TITL CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES JRNL TITL 2 WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 365 764 2008 JRNL REFN ISSN 0006-291X JRNL PMID 18035053 JRNL DOI 10.1016/J.BBRC.2007.11.036 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 30107 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1589 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2260 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3210 REMARK 3 BIN FREE R VALUE SET COUNT : 107 REMARK 3 BIN FREE R VALUE : 0.4110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7793 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 55 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.64000 REMARK 3 B22 (A**2) : -0.85000 REMARK 3 B33 (A**2) : 2.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.449 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.325 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.484 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.911 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.854 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8029 ; 0.003 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10910 ; 0.619 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 946 ; 4.952 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 355 ;33.072 ;25.408 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1461 ;17.332 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;16.587 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1182 ; 0.051 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5994 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4269 ; 0.327 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 5547 ; 0.341 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 313 ; 0.243 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 68 ; 0.333 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.370 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4829 ; 0.819 ; 1.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7796 ; 1.552 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3676 ; 1.636 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3114 ; 2.415 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VG5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1290034379. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I711 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.969 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31949 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.28450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.28450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 59.43150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 78.06350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 59.43150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 78.06350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 77.28450 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 59.43150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 78.06350 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 77.28450 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 59.43150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 78.06350 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 65 REMARK 465 LYS A 66 REMARK 465 ASP A 67 REMARK 465 SER A 68 REMARK 465 THR A 69 REMARK 465 LYS A 70 REMARK 465 PRO B 1001 REMARK 465 ILE B 1002 REMARK 465 SER B 1003 REMARK 465 PRO B 1004 REMARK 465 THR B 1215 REMARK 465 THR B 1216 REMARK 465 PRO B 1217 REMARK 465 ASP B 1218 REMARK 465 LYS B 1219 REMARK 465 LYS B 1220 REMARK 465 HIS B 1221 REMARK 465 GLN B 1222 REMARK 465 LYS B 1223 REMARK 465 GLU B 1224 REMARK 465 PRO B 1225 REMARK 465 PRO B 1226 REMARK 465 PHE B 1227 REMARK 465 LEU B 1228 REMARK 465 TRP B 1229 REMARK 465 LEU B 1283 REMARK 465 ARG B 1284 REMARK 465 GLY B 1285 REMARK 465 ARG B 1356 REMARK 465 MET B 1357 REMARK 465 ARG B 1358 REMARK 465 GLY B 1359 REMARK 465 ALA B 1360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 556 CG1 CG2 CD1 REMARK 470 ARG A 557 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ALA B 1267 O ILE B 1270 1.72 REMARK 500 OH TYR B 1354 OE1 GLU B 1370 1.90 REMARK 500 O LYS B 1323 NE2 GLN B 1343 1.97 REMARK 500 O ASP A 549 OG SER A 553 2.00 REMARK 500 O GLU A 305 N GLU A 308 2.04 REMARK 500 O VAL B 1365 OG1 THR B 1369 2.05 REMARK 500 O ARG B 1277 N CYS B 1280 2.09 REMARK 500 OG1 THR A 338 O HOH A 2016 2.13 REMARK 500 O GLN A 85 NZ LYS A 154 2.13 REMARK 500 O ASP A 17 NH1 ARG A 83 2.15 REMARK 500 OD1 ASN B 1363 N LYS B 1366 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 478 CD GLU A 478 OE2 0.077 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 20 41.51 -142.75 REMARK 500 PRO A 25 138.74 -36.05 REMARK 500 PRO A 52 11.06 -63.18 REMARK 500 GLU A 53 -73.96 -63.11 REMARK 500 ASN A 54 101.21 -32.55 REMARK 500 THR A 84 -109.75 -67.50 REMARK 500 ASP A 113 51.09 33.87 REMARK 500 ASN A 136 -105.11 -118.23 REMARK 500 ASN A 137 -149.92 -118.06 REMARK 500 GLU A 138 15.91 84.33 REMARK 500 THR A 139 117.85 -160.85 REMARK 500 PRO A 140 -92.13 -20.83 REMARK 500 LEU A 149 106.25 -58.36 REMARK 500 GLU A 169 -73.05 -39.63 REMARK 500 ASN A 175 63.07 -152.64 REMARK 500 MET A 184 -149.18 56.02 REMARK 500 ASP A 185 0.39 -53.15 REMARK 500 GLN A 197 -29.13 112.94 REMARK 500 GLN A 222 -141.93 -51.51 REMARK 500 LYS A 223 135.42 -174.43 REMARK 500 MET A 230 43.88 36.66 REMARK 500 SER A 268 2.22 -60.88 REMARK 500 ILE A 270 -20.91 -147.51 REMARK 500 LEU A 282 -18.66 -44.34 REMARK 500 ARG A 284 119.49 -21.55 REMARK 500 THR A 296 170.18 -54.91 REMARK 500 ALA A 304 -74.17 -56.01 REMARK 500 PRO A 345 92.18 -28.57 REMARK 500 PHE A 346 4.29 102.20 REMARK 500 MET A 357 87.94 -153.85 REMARK 500 TRP A 410 107.83 -178.31 REMARK 500 PRO A 412 171.49 -56.09 REMARK 500 TYR A 427 147.47 165.47 REMARK 500 ALA A 446 133.76 -175.80 REMARK 500 THR A 450 -31.41 95.94 REMARK 500 VAL A 466 24.09 -166.01 REMARK 500 VAL A 467 128.61 -36.03 REMARK 500 THR A 470 -97.35 -94.70 REMARK 500 GLU A 514 45.67 -81.41 REMARK 500 LYS A 528 -175.29 -59.08 REMARK 500 LYS A 540 -165.40 -113.26 REMARK 500 PRO B1009 87.76 -56.23 REMARK 500 LYS B1065 -126.52 -14.35 REMARK 500 ASP B1067 62.79 37.05 REMARK 500 SER B1068 -141.11 -126.52 REMARK 500 GLN B1085 -84.64 -25.02 REMARK 500 ASP B1086 -46.61 -18.57 REMARK 500 GLU B1089 -60.16 -104.52 REMARK 500 GLN B1091 -77.94 -74.08 REMARK 500 ASP B1113 -2.32 -59.95 REMARK 500 REMARK 500 THIS ENTRY HAS 75 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NNC A1551 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 REMARK 900 RELATED ID: 1HPS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SB206343 REMARK 900 RELATED ID: 1D4J RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370 REMARK 900 RELATED ID: 1R0A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED REMARK 900 TO DNA TEMPLATE -PRIMER SOLVED TO 2.8 ANGSTROMS REMARK 900 RELATED ID: 1HPZ RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1HQE RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1QE1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE REMARK 900 TRANSCRIPTASE REMARK 900 RELATED ID: 1AJX RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001 REMARK 900 RELATED ID: 1TVR RELATED DB: PDB REMARK 900 HIV-1 RT/9-CL TIBO REMARK 900 RELATED ID: 1EBK RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 REMARK 900 PROTEASE REMARK 900 RELATED ID: 1S6P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE REMARK 900 TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943 REMARK 900 RELATED ID: 1BQM RELATED DB: PDB REMARK 900 HIV-1 RT/HBY 097 REMARK 900 RELATED ID: 1IKV RELATED DB: PDB REMARK 900 K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ REMARK 900 RELATED ID: 1W5Y RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 1HOS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH SB204144 REMARK 900 RELATED ID: 1S6Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R147681 REMARK 900 RELATED ID: 1IKW RELATED DB: PDB REMARK 900 WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ REMARK 900 RELATED ID: 3HVT RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1EC1 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409 REMARK 900 RELATED ID: 1EC0 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403 REMARK 900 RELATED ID: 1T05 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMERWITH REMARK 900 TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE REMARK 900 RELATED ID: 1RVQ RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 TIBO (THEORETICAL MODEL) REMARK 900 RELATED ID: 1D4I RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425 REMARK 900 RELATED ID: 1MEU RELATED DB: PDB REMARK 900 HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 2BE2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH R221239 REMARK 900 RELATED ID: 1S9G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R120394. REMARK 900 RELATED ID: 1HNV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED REMARK 900 BY SER (C280S ) REMARK 900 RELATED ID: 1RVR RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 IMIDAZODIPYRIDODIAZEPINE (UK -129,485) (THEORETICAL MODEL) REMARK 900 RELATED ID: 1IKX RELATED DB: PDB REMARK 900 K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE REMARK 900 INHIBITOR PNU142721 REMARK 900 RELATED ID: 1W5W RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 1IKY RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194 REMARK 900 RELATED ID: 1QMC RELATED DB: PDB REMARK 900 C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES REMARK 900 RELATED ID: 1N6Q RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP- REMARK 900 TERMINATED DNA ( COMPLEX N) REMARK 900 RELATED ID: 1RVN RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 PHENYL-ISOINDOLINONE ( THEORETICAL MODEL) REMARK 900 RELATED ID: 1D4H RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435 REMARK 900 RELATED ID: 1HBV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SB203238 REMARK 900 RELATED ID: 1RTD RELATED DB: PDB REMARK 900 STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: REMARK 900 IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE REMARK 900 RELATED ID: 1HTF RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR126045 REMARK 900 RELATED ID: 1EC2 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428 REMARK 900 RELATED ID: 1W5V RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 2HMI RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE-STRANDED REMARK 900 DEOXYRIBONUCLEIC ACID AND FAB28 REMARK 900 RELATED ID: 2UY0 RELATED DB: PDB REMARK 900 TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY- REMARK 900 ALCOHOL-CONTAINING TRANSITION-STATE MIMIC REMARK 900 RELATED ID: 1SV5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) REMARK 900 IN COMPLEX WITH JANSSEN-R165335 REMARK 900 RELATED ID: 1HMV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1S9E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R129385 REMARK 900 RELATED ID: 1N5Y RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP- REMARK 900 TERMINATED DNA ( COMPLEX P) REMARK 900 RELATED ID: 1DLO RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1HEG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SKF 107457 ( HEG) REMARK 900 RELATED ID: 1RVP RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 THIAZOLOISOINDOLINONE ( THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVL RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 ALPHA-APA (R89439) ( THEORETICAL MODEL) REMARK 900 RELATED ID: 1DW6 RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 REMARK 900 PROTEASE REMARK 900 RELATED ID: 1EET RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 REMARK 900 RELATED ID: 2B6A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH THR-50 REMARK 900 RELATED ID: 1W5X RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 1HVU RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED REMARK 900 WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT REMARK 900 RELATED ID: 1HTG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR137615 REMARK 900 RELATED ID: 1EBW RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322 REMARK 900 RELATED ID: 2BAN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R157208 REMARK 900 RELATED ID: 1RDH RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN) REMARK 900 RELATED ID: 1EBY RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369 REMARK 900 RELATED ID: 1J5O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV -1 REMARK 900 REVERSETRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- REMARK 900 PRIMER REMARK 900 RELATED ID: 1HVP RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH SUBSTRATE ( THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVO RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 NEVIRAPINE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1MES RELATED DB: PDB REMARK 900 HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1EC3 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367 REMARK 900 RELATED ID: 1HIH RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820 REMARK 900 RELATED ID: 1HEF RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SKF 108738 ( HEF) REMARK 900 RELATED ID: 1HNI RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) REMARK 900 MUTANT WITH CYS 280 REPLACED BY SER (C280S) REMARK 900 RELATED ID: 1TV6 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 REMARK 900 RELATED ID: 2B5J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R165481 REMARK 900 RELATED ID: 1EBZ RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388 REMARK 900 RELATED ID: 1HYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A REMARK 900 POLYPURINE TRACT RNA:DNA REMARK 900 RELATED ID: 1MET RELATED DB: PDB REMARK 900 HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1T03 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED REMARK 900 TEMPLATE-PRIMER (COMPLEX P) REMARK 900 RELATED ID: 1AXA RELATED DB: PDB REMARK 900 ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT REMARK 900 RELATED ID: 1MER RELATED DB: PDB REMARK 900 HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 REMARK 900 RELATED ID: 3TLH RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN REMARK 900 EFFICIENT INHIBITOR OF FIV PR REMARK 900 RELATED ID: 2UXZ RELATED DB: PDB REMARK 900 TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY- REMARK 900 ALCOHOL-CONTAINING TRANSITION-STATE MIMIC REMARK 900 RELATED ID: 1SBG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386 REMARK 900 RELATED ID: 1HVK RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S,S) REMARK 900 RELATED ID: 1BQN RELATED DB: PDB REMARK 900 TYR 188 LEU HIV-1 RT/HBY 097 REMARK 900 RELATED ID: 1SUQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R185545 REMARK 900 RELATED ID: 1UWB RELATED DB: PDB REMARK 900 TYR 181 CYS HIV-1 RT/8-CL TIBO REMARK 900 RELATED ID: 1RVM RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 HEPT (THEORETICAL MODEL) REMARK 900 RELATED ID: 1HTE RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR123976 REMARK 900 RELATED ID: 1HRH RELATED DB: PDB REMARK 900 RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1HQU RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 2VG6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH REMARK 900 THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS REMARK 900 RELATED ID: 2VG7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH REMARK 900 THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS DBREF 2VG5 A 1 557 UNP P03366 POL_HV1B1 600 1156 DBREF 2VG5 B 1001 1428 UNP P03366 POL_HV1B1 600 1027 SEQRES 1 A 557 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 557 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 557 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 557 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 557 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 557 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 557 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 557 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 557 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 557 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 557 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 557 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 557 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 557 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 557 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 557 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 557 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 557 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 557 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 557 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 557 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 557 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 A 557 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 557 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 557 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 557 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 557 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 557 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 557 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 557 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 557 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 557 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 557 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 557 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 557 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 557 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 557 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 557 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 557 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 557 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 557 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 557 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 557 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG SEQRES 1 B 428 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 428 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 428 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 428 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 428 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 428 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 428 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 428 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 428 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 428 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 428 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 428 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 428 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 428 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 428 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 428 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 428 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 428 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 428 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 428 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 428 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 428 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 B 428 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 428 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 428 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 428 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 428 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 428 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 428 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 428 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 428 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 428 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 428 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN HET NNC A1551 24 HETNAM NNC O-[2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL] (4- HETNAM 2 NNC CHLOROPHENYL)THIOCARBAMATE FORMUL 3 NNC C17 H13 CL N2 O3 S FORMUL 4 HOH *55(H2 O) HELIX 1 1 THR A 27 GLY A 45 1 19 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ALA A 114 VAL A 118 5 5 HELIX 5 5 ASP A 121 LYS A 126 1 6 HELIX 6 6 TYR A 127 ALA A 129 5 3 HELIX 7 7 GLY A 155 ASN A 175 1 21 HELIX 8 8 GLU A 194 ARG A 211 1 18 HELIX 9 9 ASP A 218 GLN A 222 5 5 HELIX 10 10 THR A 253 SER A 268 1 16 HELIX 11 11 VAL A 276 LEU A 282 1 7 HELIX 12 12 THR A 296 LEU A 310 1 15 HELIX 13 13 ASN A 363 GLY A 384 1 22 HELIX 14 14 GLN A 394 TYR A 405 1 12 HELIX 15 15 GLN A 475 SER A 489 1 15 HELIX 16 16 SER A 499 ALA A 508 1 10 HELIX 17 17 SER A 515 LYS A 528 1 14 HELIX 18 18 GLY A 544 SER A 553 1 10 HELIX 19 19 THR B 1027 GLU B 1044 1 18 HELIX 20 20 PHE B 1077 ARG B 1083 1 7 HELIX 21 21 THR B 1084 GLU B 1089 1 6 HELIX 22 22 GLY B 1099 LYS B 1103 5 5 HELIX 23 23 GLY B 1112 TYR B 1115 5 4 HELIX 24 24 ASP B 1121 ALA B 1129 5 9 HELIX 25 25 SER B 1134 GLU B 1138 5 5 HELIX 26 26 LYS B 1154 ASN B 1175 1 22 HELIX 27 27 GLU B 1194 ARG B 1211 1 18 HELIX 28 28 HIS B 1235 TRP B 1239 5 5 HELIX 29 29 THR B 1253 GLN B 1269 1 17 HELIX 30 30 THR B 1296 ILE B 1309 1 14 HELIX 31 31 ASN B 1363 GLY B 1384 1 22 HELIX 32 32 GLN B 1394 TRP B 1402 1 9 HELIX 33 33 THR B 1403 TYR B 1405 5 3 HELIX 34 34 PRO B 1420 TYR B 1427 1 8 SHEET 1 AA 3 ILE A 47 LYS A 49 0 SHEET 2 AA 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 AA 3 PHE A 130 ILE A 132 -1 O PHE A 130 N TYR A 144 SHEET 1 AB 2 VAL A 60 ILE A 63 0 SHEET 2 AB 2 ARG A 72 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 AC 3 SER A 105 ASP A 110 0 SHEET 2 AC 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 AC 3 VAL A 179 TYR A 183 -1 O VAL A 179 N GLY A 190 SHEET 1 AD 3 PHE A 227 TRP A 229 0 SHEET 2 AD 3 TYR A 232 LEU A 234 -1 O TYR A 232 N TRP A 229 SHEET 3 AD 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 AE 5 ASN A 348 TYR A 354 0 SHEET 2 AE 5 TRP A 337 TYR A 342 -1 O TRP A 337 N TYR A 354 SHEET 3 AE 5 ILE A 326 LYS A 331 -1 O ILE A 326 N TYR A 342 SHEET 4 AE 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 AE 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 AF 2 HIS A 361 THR A 362 0 SHEET 2 AF 2 LYS A 512 SER A 513 -1 O LYS A 512 N THR A 362 SHEET 1 AG 5 GLN A 464 LYS A 465 0 SHEET 2 AG 5 GLY A 453 THR A 459 -1 O TYR A 457 N LYS A 465 SHEET 3 AG 5 THR A 439 GLY A 444 -1 O TYR A 441 N VAL A 458 SHEET 4 AG 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 AG 5 LYS A 530 TRP A 535 1 O LYS A 530 N VAL A 493 SHEET 1 AH 3 GLN A 464 LYS A 465 0 SHEET 2 AH 3 GLY A 453 THR A 459 -1 O TYR A 457 N LYS A 465 SHEET 3 AH 3 PRO A 468 LEU A 469 -1 O LEU A 469 N GLY A 453 SHEET 1 BA 3 ILE B1047 LYS B1049 0 SHEET 2 BA 3 ILE B1142 TYR B1146 -1 O GLN B1145 N SER B1048 SHEET 3 BA 3 PHE B1130 ILE B1132 -1 O PHE B1130 N TYR B1144 SHEET 1 BB 2 VAL B1060 LYS B1064 0 SHEET 2 BB 2 TRP B1071 VAL B1075 -1 O ARG B1072 N ILE B1063 SHEET 1 BC 4 VAL B1179 GLN B1182 0 SHEET 2 BC 4 ASP B1186 SER B1191 -1 O TYR B1188 N TYR B1181 SHEET 3 BC 4 SER B1105 ASP B1110 -1 O SER B1105 N SER B1191 SHEET 4 BC 4 GLU B1233 LEU B1234 -1 O LEU B1234 N VAL B1106 SHEET 1 BD 5 LYS B1347 TYR B1354 0 SHEET 2 BD 5 TRP B1337 GLU B1344 -1 O TRP B1337 N TYR B1354 SHEET 3 BD 5 ILE B1326 LYS B1331 -1 O ILE B1326 N TYR B1342 SHEET 4 BD 5 LYS B1388 LEU B1391 1 O LYS B1388 N ALA B1327 SHEET 5 BD 5 TRP B1414 PHE B1416 1 O GLU B1415 N LEU B1391 CISPEP 1 PRO A 225 PRO A 226 0 5.21 CISPEP 2 PRO A 420 PRO A 421 0 -0.33 SITE 1 AC1 13 LEU A 100 LYS A 101 LYS A 103 VAL A 106 SITE 2 AC1 13 VAL A 179 TYR A 181 TYR A 188 PHE A 227 SITE 3 AC1 13 TRP A 229 LEU A 234 HIS A 235 TYR A 318 SITE 4 AC1 13 GLU B1138 CRYST1 118.863 156.127 154.569 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008413 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006405 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006470 0.00000